The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034) — Boston, Massachusetts

The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034) is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034) has participated in 1 clinical trials.

Therapeutic areas: Neurofibroma, Plexiform, Neurofibromatosis Type I.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034)?

The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034) conducted?

The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034) has 1 clinical trials on record. Their work covers Neurofibroma, Plexiform, Neurofibromatosis Type I.

Is The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034) accredited by Crixeo Health?

The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Children's Hospital, Dana-Farber Cancer Institute, Boston, MA (M1034)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.